Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D. Lagerlöf I, et al. Among authors: molin d. Br J Haematol. 2020 Mar;188(5):685-691. doi: 10.1111/bjh.16232. Epub 2019 Oct 14. Br J Haematol. 2020. PMID: 31612478 Free article. Clinical Trial.
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Jakobsen LH, Hutchings M, de Nully Brown P, Linderoth J, Mylam KJ, Molin D, Johnsen HE, Bøgsted M, Jerkeman M, El-Galaly TC. Jakobsen LH, et al. Among authors: molin d. Br J Haematol. 2016 Apr;173(2):236-44. doi: 10.1111/bjh.13943. Epub 2016 Feb 5. Br J Haematol. 2016. PMID: 26846879 Free article.
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Lagerlöf I, Fohlin H, Enblad G, Glimelius B, Goldkuhl C, Palma M, Åkesson L, Glimelius I, Molin D. Lagerlöf I, et al. Among authors: molin d. J Clin Oncol. 2022 May 1;40(13):1487-1496. doi: 10.1200/JCO.21.02407. Epub 2022 Jan 25. J Clin Oncol. 2022. PMID: 35077204 Free PMC article.
Checkpoint CD47 expression in classical Hodgkin lymphoma.
Gholiha AR, Hollander P, Löf L, Glimelius I, Hedstrom G, Molin D, Hjalgrim H, Smedby KE, Hashemi J, Amini RM, Enblad G. Gholiha AR, et al. Among authors: molin d. Br J Haematol. 2022 Jun;197(5):580-589. doi: 10.1111/bjh.18137. Epub 2022 Mar 17. Br J Haematol. 2022. PMID: 35301709 Free PMC article.
151 results